loading

Adverum Biotechnologies Inc Stock (ADVM) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - 3.60
Operating Expenses
2.60%
26.84
26.16 34.53 33.06 33.84
Depreciation and Amortization
1.19%
0.997
1.009 1.509 1.534 1.592
Operating Income/Loss
2.60%
-26.84
-26.16 -34.53 -33.06 -30.24
Nonoperating Income/Loss
56.52%
2.052
1.311 1.661 1.576 1.20
Income/Loss From Continuing Operations Before Tax
0.24%
-24.79
-24.85 -32.87 -31.49 -29.04
Income Tax Expense/Benefit
100.00%
-
-1.133 0.017 0.021 0.017
Income/Loss From Continuing Operations After Tax
4.52%
-24.79
-23.71 -32.88 -31.51 -29.06
Net Income/Loss
4.52%
-24.79
-23.71 -32.88 -31.51 -29.06
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
12,479%
16.48
0.131 101.00 100.77 100.30
Diluted Average Shares
12,479%
16.48
0.131 101.00 100.77 100.30
Basic Earnings Per Share
552.17%
-1.50
-0.23 -0.33 -0.31 -0.29
Diluted Earnings Per Share
552.17%
-1.50
-0.23 -0.33 -0.31 -0.29
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):